Grace Therapeutics Inc. (GRCE)
NASDAQ: GRCE
· Real-Time Price · USD
3.01
0.02 (0.84%)
At close: Jun 26, 2025, 11:33 AM
0.84% (1D)
| Bid | 2.89 |
| Market Cap | 41.29M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -13.37M |
| EPS (ttm) | -1.53 |
| PE Ratio (ttm) | -1.97 |
| Forward PE | -3.16 |
| Analyst | Buy |
| Ask | 3.08 |
| Volume | 16,040 |
| Avg. Volume (20D) | 33,648 |
| Open | 2.96 |
| Previous Close | 2.98 |
| Day's Range | 2.96 - 3.01 |
| 52-Week Range | 1.75 - 4.97 |
| Beta | 0.91 |
About GRCE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GRCE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for GRCE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
+8.33%
Grace Therapeutics shares are trading higher after...
Unlock content with
Pro Subscription
